About this trial
In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.
Eligibility criteria
Qualifiers
Primigravidae with the full term undergoing vaginal delivery with episiotomy.
Pregnancies and singleton vertex cephalic fetuses.
In the active phase of the first stage of labor.
Disqualifiers
Patients with history of drug allergies to study drugs as this will increase the risk of complications.
Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs.
Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications.
Inability to cooperate as this will affect our assessment.
Trial design
Treatments tested in this trial
- Lignocaine
- Bupivacaine